Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
RA Capital
Biotech
Sanofi-backed Expedition lands $115M for ph. 2 COPD trial
Expedition secured an oversubscribed $115 million series B from a line-up of big-name investors to propel its lead DPP1 inhibitor through phase 2.
Marissa Russo
Aug 5, 2026 8:00am
RA Capital launches Oak Hill Bio onto the Nasdaq via SPAC
Jul 27, 2026 3:25pm
How RA Capital is offering ‘Chinese clinical expertise in a box’
Jun 5, 2026 8:19am
A divisive bill seeks to limit biotech investment in China
Jun 4, 2026 10:54am
CellCentric raises $220M to advance myeloma drug
May 6, 2026 7:00am
Windward breezes toward phase 3 with $165M for TSLP ambitions
May 4, 2026 10:31am
